ERBB2 and neoplasm: Whole body PET imaging of tumour-bearing mice demonstrated greater tumour uptake of [18F]F-FSB-SH-1194-35 in BT474 cancer cells, compared to MDA-MB-231 tumours, indicating the specificity of the radiolabelled aptamer for targeting HER2 in vivo [27].